会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Process for producing cold rolled steel strip having excellent
mechanical strength and useful for motor vehicles
    • 制造机械强度优异且用于机动车辆的冷轧钢带的制造方法
    • US4391653A
    • 1983-07-05
    • US302450
    • 1981-09-15
    • Hiroshi TakechiHiroshi KatohKazuo KoyamaKazuhide Usami
    • Hiroshi TakechiHiroshi KatohKazuo KoyamaKazuhide Usami
    • C22C38/00B21B3/02C21D8/02C21D8/04C21D9/46
    • C21D9/46B21B3/02C21D8/0436C21D8/0426C21D8/0473
    • A high strength cold rolled strip having excellent deep drawability and resistance to deterioration by natural aging and to planar cracking and useful for motor vehicles, is produced by hot rolling a steel slab comprising0.008-0.020% by weight of C,0.01-0.45% by weight of Mn,0.05-0.10% by weight of P,0.005-0.050% by weight of acid-soluble Al,and the balance consisting of Fe and unavoidable impurities in which N is limited to a content of 40 ppm or less, at a temperature of 1200.degree. C. or less but not lower than the Ar.sub.3 point of the steel slab; by cold rolling the resultant steel strip at a rolling reduction of 65% or more; by continuously annealing the cold rolled steel strip at a temperature of from 700.degree. to 900.degree. C. for 20 seconds to 3 minutes; by cooling the steel strip at a cooling rate of 5.degree. C./sec or more; by overaging the annealed steel strip at a temperature of from 320.degree. to 450.degree. C. for 1 to 10 minutes; by cooling said overaged steel strip to the ambient temperature, and, finally; by temper-rolling the cooled steel strip at the ambient temperature.
    • 通过将包含0.008-0.020重量%的C,0.01-0.45%的钢坯热轧在钢坯上,制造具有优异的深冲性和耐自然老化劣化和平面裂纹并且适用于机动车辆的高强度冷轧带 Mn重量为0.05-0.10%,P为0.005-0.050%(重量),余量由Fe和不可避免的杂质组成,其中N被限制在40ppm以下的含量 温度在1200℃以下但不低于钢坯的Ar3点; 通过在65%以上的压下率下冷轧得到的钢带; 通过在700〜900℃的温度下连续退火冷轧钢带20秒〜3分钟; 通过以5℃/秒以上的冷却速度冷却钢带; 通过在320℃至450℃的温度下对退火的钢带进行1至10分钟的老化处理; 通过将所述过时的钢带冷却至环境温度,最后; 通过在环境温度下冷却冷却的钢带。
    • 5. 发明授权
    • Amplifier circuit
    • 放大器电路
    • US08766715B2
    • 2014-07-01
    • US13511233
    • 2011-08-29
    • Kazuo Koyama
    • Kazuo Koyama
    • H03F3/45
    • H03F3/45475H03F3/3022H03F3/45183H03F3/45928H03F2203/45082H03F2203/45528
    • An amplifier circuit capable of reducing load of a circuit at the previous stage by providing increased input impedance producing less noises. The amplifier circuit includes a fully-differential operational amplifier composed of an inverting input terminal, a non-inverting input terminal receiving a signal different from a signal to be input to the inverting input terminal, an inverting output terminal with the same polarity of the inverting input terminal, and a non-inverting output terminal with reverse polarity; an input impedance element with one end connected to the inverting input terminal; an input impedance element with one end connected to the non-inverting input terminal; and positive feedback impedance elements, with one end of connected to the other end of the input impedance element and the other end connected to the inverting output terminal or to the non-inverting output terminal.
    • 一种放大器电路,其能够通过提供增加的输入阻抗产生较少的噪声来减小前一电路的负载。 放大器电路包括由反相输入端子,非反相输入端子接收与要输入到反相输入端子的信号不同的信号的全差分运算放大器,反相输出端子具有与反相输入端子相同极性的反相输出端子 输入端子和反相输出端子; 输入阻抗元件,其一端连接到反相输入端子; 输入阻抗元件,其一端连接到非反相输入端子; 和正反馈阻抗元件,其一端连接到输入阻抗元件的另一端,另一端连接到反相输出端或非反相输出端。
    • 8. 发明授权
    • Benzylamine analogues
    • 苄胺类似物
    • US07514475B2
    • 2009-04-07
    • US11583499
    • 2006-10-19
    • Kazuo KoyamaShinji MarumotoNarihiro TodaHiroshi KogenKeiko Suzuki
    • Kazuo KoyamaShinji MarumotoNarihiro TodaHiroshi KogenKeiko Suzuki
    • A61K31/137C07C205/04
    • C07C219/30C07C271/44C07C323/20C07C323/25C07C333/04C07D213/64C07D213/68C07D215/20C07D317/58C07D333/38
    • A compound of the formula (I): wherein R1 is a C1-C6 alkyl, an amino, a (C1-C6 alkyl)amino, a di(C1-C6 alkyl)amino or a nitrogen-containing saturated heterocyclic; R2 and R3 are the same or different and are a hydrogen or a C1-C6 alkyl; Arom is an unsubstituted or substituted aryl or an unsubstituted or substituted heteroaryl; wherein the substituted aryl is substituted at 1 to 5 positions and the substituted heteroaryl is substituted at 1 to 3 positions; wherein the heteroaryl is furyl, thiolyl, pyrrolyl, azepinyl, pyrazolyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, 1,2,3 oxadiazolyl, pyranyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl or quinolyl; and wherein the substituents of the substituted aryl and of the substituted heteroaryl are independently halogen, C1-C6 alkyl, halogeno C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylthio, C1-C3 alkylenedioxy, C1-C7 alkanoyl, C2-C7 alkyloxycarbonyl, amino, C1-C7 alkanoylamino, hydroxyl, mercapto, cyano, nitro or carboxyl; A is an ethylene or propylene; Ra is a hydrogen, a C1-C6 alkyl or a C2-C6 alkenyl; E is a single bond, an oxygen, a sulfur or —NR4—, wherein R4 is a hydrogen or a C1-C7 alkanoyl; X1 and X2 are the same or different and are an oxygen or a sulfur, or a pharmacologically acceptable salt or ester thereof.
    • 式(I)的化合物:其中R1是C1-C6烷基,氨基,(C1-C6烷基)氨基,二(C1-C6烷基)氨基或含氮饱和杂环; R2和R3相同或不同,为氢或C1-C6烷基; Arom是未取代或取代的芳基或未取代或取代的杂芳基; 其中取代的芳基在1至5个位置被取代,并且取代的杂芳基在1至3个位置被取代; 吡唑基,咪唑基,恶唑基,异恶唑基,噻唑基,异噻唑基,1,2,3-恶二唑基,吡喃基,吡啶基,哒嗪基,嘧啶基,吡嗪基或喹啉基;其中杂芳基为呋喃基,噻吩基,吡咯基, 并且其中取代的芳基和取代的杂芳基的取代基独立地为卤素,C 1 -C 6烷基,卤代C 1 -C 6烷基,C 1 -C 6烷氧基,C 1 -C 6烷硫基,C 1 -C 3亚烷基二氧基,C 1 -C 7烷酰基, C7烷氧基羰基,氨基,C1-C7烷酰基氨基,羟基,巯基,氰基,硝基或羧基; A是乙烯或丙烯; R a是氢,C 1 -C 6烷基或C 2 -C 6烯基; E是单键,氧,硫或-NR4-,其中R4是氢或C1-C7烷酰基; X1和X2相同或不同,为氧或硫,或其药理学上可接受的盐或酯。